Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients
Figure 1
The lines show individual changes of mean arterial pressure (MAP) and heart rate (HR) of nonresponders and responders during the 2 h observation period.
